Issuu on Google+



table of contents

Pages 1 Table of contents 2 PGEU Brussels, 3 Exposition photos 4 Exposition purpose 5 Belgium 1959 6 France 1959 7 Italy 1959 8 Germany 1959 9 Netherlands 1959 10 Greece 1960 11 Austria 1964 12 Ireland 1964 13 Norway 1964 14 Spain 1964 15 Sweden 1964 16 UK 1964 17 Denmark 1973 18 Portugal 1975 19 Finland 1979 20 Cyprus 1996 21 Poland 1996 22 Slovenia 1996 23 Czech 1997 24 Slovakia 1997 25 Latvia 2000 26 Turku 2001 27 Bulgaria 2004 28 29 30

The PGEU Secretariat Rue du Luxembourg 19-21, 1000 Brussels, Belgium telephone - +32 (0) 2 238 0818 fax - +32 (0) 2 238 0819

Names of staff members and their positions and contribution to the project /exposition

The people of PGEU Brussels were happy to bring the exposition alive and honour all its member countries for their contribution to the bettering of pharmacy in the European Union for the past 50 years

Names of staff members and their positions and contribution to the project/exposition

The exposition night was a great success with people from all over the European Union gathering to celbrate 50 years of pharmacy.

The program included keynite speaker and head of the PGEU, SSSSSSS, followed by HHHHHHHHHHHHHH. Each banner contained text submitted by each member country participating explaining what they found to be of historical importance to their countries pharmacy; Each countries’ banner was unique to its cultural and exemplary to their thinking and progress. The 26 participating countries banners were standing the European Parliment in Brussels for the week of XXX to XXX. With thise banners exstensive pamphlet based information was provided on health and pharmacy and pharmacists were standing by to take blood pressure and answer any questions. In the next pages are all the countrue’s banners for all to read. Congratulations to all who participated.

Belgian patients protected by their pharmacist: a unique approach on quality assurance Belgium was a founder member of PGEU in 1959 For the last 50 years, Belgian pharmacists are continuously adding extra layers of confidence to the quality of the products they dispense. Historically, the Pharmaceutical Practice Law of 1885 introduced the principle of “NO FAULT responsibility”, meaning that the pharmacist has final responsibility for every product (s)he dispenses. Milestones have been set out to prevent patients being confronted to sub-standard medicine : [1949] ORDRE DES PHARMACIENS  Created to decommercialise the profession.  Introduction of a continually updated Deontology Code applicable to all practicing pharmacists, to serve the patients interests and public health:  Article 1(2) The pharmacist is at the service of Public Health. He practices his activity on the patient’s interest. Through out his entire career he must be competent and committed.  Article 6 He dispenses but high quality pharmaceutical care and health products.  Article 17 The pharmacist seeks to serve the patient’s interest by putting his competence and commitment to the service of all individuals without any form of discrimination.  Article 36 When dispensing, and if needed, the pharmacist clearly informs the patient about how the medicine works, its contra-indications, side effects, interactions, possible precautionary measures, doses and how to take it, without, at the same time, undermining the patient’s confidence on the medicine.  Article 40 He must oppose to over-consumption in case of self-medication, alert the patient to its negative consequences and advise him to consult a doctor.  

[1952] MEDICINES CONTROL LAB (MCL) Start-up to combat post-war fraud of penicillin-containing pharmaceuticals Independent Quality Control Laboratory, operated by APB (Association of Pharmacists in Belgium) in conjunction with the Drug Regulatory Agency of the Ministry of Health  Financed by all Belgian pharmacies through a contribution per pack  Staff : ± 55 (pharmacists & lab technicians)  ISO 17025 accredited  Systematic re-analysis of all registered medicines, sampled at wholesaler level  In case of non-conformity : centralized recall procedure, owned by MCL [1953] QUALITY LABEL FOR PARAPHARMACEUTICALS Quality Label for cosmetics, food supplements, plant preparations, medical devices, etc.  Producer has to apply for a Label, and submits all relevant information on production, formulation, stability, safety, analysis, clinical evidence, etc.  Application is studied by independent commission  If LABEL is granted, the product is periodically analysed by MCL  The European Commission approved the Label agreement 

[2006] AUTHENTICATION SYSTEM TO COMBAT COUTERFEITING Belgian Healthcare Authorities introduced a Unique Barcode per package of reimbursed pharmaceuticals to combat healthcare insurance fraud (2004)  APB and Aegate collaborate to use existing mass serialisation to combat counterfeiting of medicines  First launch worldwide of an authentication system at the point of dispensing – using secure technology  Logical extension of APB’s efforts relating to quality assurance of pharmaceuticals and to patient safety  A system to provide patient safety, allowing pharmacists to authenticate products at the moment of dispensing to the patient  No interference with the work flow, fully integrated in the existing software, extremely fast (internet) response time.  The system will generate warnings or special messages in real-time in case of products that are: • counterfeit • recalled • stolen • expired • about to be discontinued  Effectiveness was confirmed by an independent audit by the Katholieke Universiteit Leuven (2008) 

CONCLUSION For over 50 years, Belgian pharmacists are developing and implementing rigorous and state-of-the-art measures to guarantee that their patients receive medicines of unquestionable quality.

pgeu webpamphlet